Actively Recruiting

Phase 2
Age: 18Years - 89Years
All Genders
Healthy Volunteers
NCT06665594

Effect of TXA on Reducing Bruising After Filler Injection

Led by University of Wisconsin, Madison · Updated on 2026-02-03

40

Participants Needed

1

Research Sites

47 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

The goal of this clinical trial is to look at the effect tranexamic acid (TXA) may have on reducing bruising, swelling, and pain after facial filler injection. The main question it aims to answer is: * Does the addition of TXA to hyaluronic acid (HA) reduce bruising, swelling, and tenderness after HA injection? Participants will receive the study medication along with the standard facial filler injection and complete surveys.

CONDITIONS

Official Title

Effect of TXA on Reducing Bruising After Filler Injection

Who Can Participate

Age: 18Years - 89Years
All Genders
Healthy Volunteers

Eligibility Criteria

Eligible

You may qualify if you...

  • Age equal to or greater than 18 but less than or equal to 89 years.
  • Participants interested in facial filler (HA) injection.
  • English speaking.
Not Eligible

You will not qualify if you...

  • Minors or under the age of 18
  • Participant over the age of 89
  • Pregnant or breast-feeding women
  • Individuals unable to give consent due to another condition such as impaired decision-making capacity.
  • Individuals with a history of a thrombotic event (DVT, PE, stroke, MI) or genetic disorder that increases risk of thrombosis
  • Participants undergoing unilateral facial filler (HA) injection
  • Participants with history of hypersensitivity to TXA or any of the other ingredients
  • Participants that are on current therapeutic anticoagulation therapy and aspirin use
  • Participants with stage 2 or greater renal failure
  • Participants on hemodialysis or peritoneal dialysis
  • History of diabetes or seizures
  • Current tobacco smokers
  • Acquired defective color vision

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

University of Wisconsin - Madison

Madison, Wisconsin, United States, 53705

Actively Recruiting

Loading map...

Research Team

A

Armin Edalatpour, MD

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

NONE

Allocation

NA

Model

SINGLE_GROUP

Primary Purpose

SUPPORTIVE_CARE

Number of Arms

1

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here